Used as an intermediate in the synthesis of rosuvastatin, a potent HMG-CoA reductase inhibitor prescribed to lower cholesterol and reduce the risk of cardiovascular diseases. This ester form facilitates specific steps in the manufacturing process, improving yield and purity during the production of the active pharmaceutical ingredient. It is not intended for direct therapeutic use but plays a critical role in the efficient large-scale synthesis of the final drug substance.